Alnylam Pharmaceuticals
ALNY
#433
Rank
HK$421.96 B
Marketcap
HK$3,194
Share price
1.48%
Change (1 day)
61.81%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company